データを補完しています。しばらくしてからページを更新すると最新の内容を表示できます
1262052-36-7CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H]1CJQXXHWHPUNPDRT-WQCUSGOUSA-N1262052-36-7安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。
説明Rifampicin-d3 is intended for use as an internal standard for the quantification of rifampicin by GC- or LC-MS. Rifampicin is a rifamycin antibiotic and inhibitor of bacterial RNA polymerase (IC50 = 0.01 μg/ml for the E. coli enzyme). It inhibits the growth of M. tuberculosis H37Rv in mouse peritoneal macrophages (MIC = 0.8 μg/ml) as well as clinical isolates of various species of Staphylococcus, Streptococcus, Haemophilus, and Neisseria (MICs = 0.009-1.4 μg/ml). Rifampicin increases survival in a mouse model of tuberculosis infection. It is also an agonist of the human pregnane X receptor (PXR; EC50 = ~2 μM). Formulations containing rifampicin have been used in the treatment of tuberculosis and meningococcal carriers.
使用Semisynthetic antibiotic. Antibacerial (tuberculostatic).
現在のフィルター条件では反応記録がありません。
読み込み中…